| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C0010362> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C0032114> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C0033106> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C0034861> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C0040053> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C0042971> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C0086174> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C0087086> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33662796_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Baxalta Innovations GmbH, a Takeda company, Vienna, Austria.\', \'School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.\', \'University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; K J Somaiya Superspecialty Hospital and Research Centre, Mumbai, India.\', \'University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.\', \'Imperial College London, Hammersmith Hospital, London, United Kingdom.\', \'University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.\', \'Baxalta US Inc., a Takeda company, Cambridge, MA, USA.\', \'Baxalta GmbH, a Takeda company, Zurich, Switzerland.\', \'Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH, Vienna, Austria.\', \'School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom. Electronic address: a.mumford@bristol.ac.uk.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Binder_Nikolaus_B> <https://research.tib.eu/covid-19/entity/Dushianthan_Ahilanandan> <https://research.tib.eu/covid-19/entity/Erdlenbruch_Wolfhard> <https://research.tib.eu/covid-19/entity/Ewenstein_Bruce_M> <https://research.tib.eu/covid-19/entity/Gritsch_Herbert> <https://research.tib.eu/covid-19/entity/Jain_Nisha> <https://research.tib.eu/covid-19/entity/James_Izabela> <https://research.tib.eu/covid-19/entity/Kazmi_Rashid> <https://research.tib.eu/covid-19/entity/Laffan_Michael_A> <https://research.tib.eu/covid-19/entity/Mellgard_Bjorn> <https://research.tib.eu/covid-19/entity/Mumford_Andrew_D> <https://research.tib.eu/covid-19/entity/Peck_Rachel_C> <https://research.tib.eu/covid-19/entity/Rangarajan_Savita> <https://research.tib.eu/covid-19/entity/Reilly-Stitt_Christopher> <https://research.tib.eu/covid-19/entity/Schrenk_Gerald> <https://research.tib.eu/covid-19/entity/Turecek_Peter_L>
?:doi	S0049-3848(21)00060-810.1016/j.thromres.2021.02.012
?:doi	<https://research.tib.eu/covid-19/entity/S0049-3848%2821%2900060-810.1016/j.thromres.2021.02.012>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Thrombosis research
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33662796>
?:pmid	<https://research.tib.eu/covid-19/entity/33662796>
?:pmid	33662796
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.096
?:rankingScore_hIndex	99
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C1336938_INHIBITS_C1413036>
?:title	Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Baxalta Innovations GmbH, a Takeda company, Vienna, Austria.\', \'School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.\', \'University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; K J Somaiya Superspecialty Hospital and Research Centre, Mumbai, India.\', \'University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.\', \'Imperial College London, Hammersmith Hospital, London, United Kingdom.\', \'University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.\', \'Baxalta US Inc., a Takeda company, Cambridge, MA, USA.\', \'Baxalta GmbH, a Takeda company, Zurich, Switzerland.\', \'Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH, Vienna, Austria.\', \'School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom. Electronic address: a.mumford@bristol.ac.uk.\']

?:citedBy